Skip to main content

Association donates N10m for production of sickle cell drug

Pharmaceutical Society of Nigeria

The Pharmaceutical Society of Nigeria (PSN) has donated N10 million to the National Institute of Pharmaceutical Research and Development (NIPRD) to boost the production of NIPRISAN.

NIPRISAN is a drug used for the management of sickle cell anaemia.

Mr Ahmed Yakasai, President of the association, made the donation when the society visited the NIPRD Director-General, Prof. Karyinus Gamaniel, on Tuesday in Abuja.

Yakasai noted that the institute had not been producing much of the drugs, thus the concern of the society to help the public with regard to efficient healthcare services.

According to him, the seed money will be used to revive the institute.

The PSN president urged the institute to from next week resume mass production of the drugs and flood the market.

Yakasai, who described the institute as a centre of excellence, assured of NIPRISAN’s commitment to collaborate with both national and international bodies to boost its research and production capacity, among others.

“The institute has been looking for investors to assist in the production of NIPRISAN for the sickle cell drugs and they are not producing much and this is social service.

“Pharmaceutical Society of Nigeria believes in helping the public as far as health care is concern.

“We are giving a seed money to revive the place to start producing NIPRISAN for the good of the common man.

“We are investing N10 million into the production of the drug immediately.

“And the institute will start production from next week and it will flood the market. Instead of producing few tablets it will be in thousands now.

“We are really going for industrialisation, we must promote research and development also we are collaborating with the institute and will be its ambassador.

“The society will lobby national and international levels to meet its funding gaps, support policies geared toward boosting the institute.

“It also will look for other partners in trade industries so that they can benefit in terms of financing research and development,” Yakasai said.

Earlier, the NIPRD director-general noted that the institute was established with the support of the society, describing PSN task as a watchdog over the activities of the institute.

However, Gamaniel said that the institute would explore available ways of increasing the internally generated revenue from the various services it renders.

According to him, if NIPRD is able to scale up the production of NIPRISAN through the support of the society it would render good services and further boost the financial capability of the institute.

Gamaniel, who identified NIPRISAN as the best medicine currently for the management of sickle cell anaemia, however appealed for the support of pharmaceutical industries in the manufacturing of the drug, among others.

He said that the society was aimed at ensuring good pharmacy practice, adding that they offer professional advice to all governments and stakeholders in the health sector on drugs and related issues.

The director-general noted that management of disease conditions and ill health all over the world revolves round access to good medicines and technology.

He, however, solicited for the collaboration of PSN, describing such collaboration as the only practical way the nation can achieve the goals of impacting positively on the citizens.

Gamaniel noted that the institute was collaborating with the society on projects aimed at obtaining clear understanding of the pharmaceutical industry in Nigeria.

“PSN is the strongest voice which we can use to advice government on certain issues.

“There is need for the society and NIPRD to work out a strategy for generating and using scientific evidence to strengthen our own voice and make meaningful impact.

“If we do not work together it will be difficult to achieve the goal of establishing NIPRD and indeed the impact of pharmacy and healthcare in the country.

“We will work with the society to carry out a study to determine the impact of national health programmes and policies on the pharmaceutical sector in Nigeria,’’ said the director-general.

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Pope not involved in Colombian peace deal- Vatican

Pope Francis Pope Francis has turned down a request to play a role in the peace deal between the Colombian government and the Revolutionary Armed Forces of Colombia (FARC) rebel group. The Vatican in a statement issued on Wednesday in in Vatican City said that an invitation was sent to his Holiness in early August to appoint a representative to participate in the committee that selected the judges for the talks. The statement said that though Pope Francis supported the peace process, he, however, reiterated that he would not get involved in Colombian peace deal. It said that Pope was praying for the enlightenment of the hearts and minds of those who were called to promote the common good of the Colombian nation. A deal was announced last week, putting an end to five decades of internal conflict between government forces and the FARC rebels. The agreement, which needed to be ratified through a referendum in Oct. 2, would entail setting up a special court to grant amnesties or pu...
Post a Comment
Read more

Houthis Claim Attack on Central Israel in Response to Gaza ‘Massacres’

The ongoing conflict between Israel and Hamas has taken a concerning regional turn as the Houthi rebels in Yemen claimed responsibility for an attack on central Israel. The group announced this as part of their escalating response to what they describe as "massacres" in Gaza amid the Israeli military’s operations in the strip. Details of the Attack The Houthis, a Shiite militant group with ties to Iran, declared that they launched missile and drone strikes targeting Israel. While the exact impact of these attacks remains unclear, reports suggest that Israel’s defense systems intercepted several threats over its airspace. This marks a significant escalation as the Houthis widen their involvement in the conflict beyond their typical operations within Yemen and neighboring Saudi Arabia. The Houthis’ Justification In their statement, the Houthis framed the attack as retaliation for Israel’s military actions in Gaza, which they characterized as indiscriminate bombings resultin...
Post a Comment
Read more

Fall of Assad is a Blow to Russia's Prestige

The potential fall of Syrian President Bashar al-Assad, a long-standing ally of Russia, would mark a turning point in Moscow’s global influence, particularly in the Middle East. Steve Rosenberg’s analysis underscores the profound implications for Russia, which has invested heavily—both militarily and politically—in ensuring Assad’s survival over the past decade. This article delves into why Assad’s downfall would strike at the core of Russian prestige and what it could mean for the broader geopolitical landscape. Russia's Strategic Commitment to Syria Since the outbreak of the Syrian civil war in 2011, Russia has been a staunch supporter of Assad's regime. In 2015, Moscow launched a military intervention that proved decisive in stabilizing Assad’s hold on power. This intervention solidified Russia's role as a key power broker in the Middle East and demonstrated its willingness to project military power far beyond its borders. Syria is not just an ally for Russia; it is a...
Post a Comment
Read more